
Quarterly Result31 Jul 2026, 07:30 pm
Aarti Drugs Declares Audited Q1 FY27 Financial Results
AI Summary
Aarti Drugs Ltd announced its audited standalone and consolidated financial results for the quarter ended June 30, 2026. The Board of Directors approved these results in a meeting held on July 31, 2026. The company has made arrangements to publish the financial results in newspapers as per SEBI regulations. The financial results were reviewed by the Audit Committee and the Board of Directors, with statutory auditors providing an unmodified audit opinion. The company operates in a single business segment: pharmaceuticals.
Key Highlights
- Board approved audited standalone and consolidated financial results.
- Results are for the quarter ended June 30, 2026 (Q1 FY27).
- Auditor's report provided an unmodified audit opinion.
- Company operates in a single pharmaceutical business segment.
- Results will be published in newspapers and uploaded online.
Price Impact
More from AARTIDRUGS